BusulfanMedication ErrorsMedication AdherenceTransplantation ConditioningMyeloablative AgonistsBone Marrow TransplantationAntineoplastic Agents, AlkylatingMedication ReconciliationMedication SystemsHepatic Veno-Occlusive DiseaseCyclophosphamideMedication Systems, HospitalTransplantation, HomologousVidarabineGraft vs Host DiseaseWhole-Body IrradiationAlkylating AgentsDrug MonitoringTransplantation, AutologousImmunosuppressive AgentsTreatment OutcomePrescription DrugsSelf MedicationDrug PrescriptionsMelphalanPolypharmacyPatient ComplianceThiotepaDrug TherapyGraft SurvivalRetrospective StudiesPsychotropic DrugsDrug PackagingCombined Modality TherapyHematologic NeoplasmsAdministration, OralLeukemiaSulfonic AcidsAntipsychotic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesSpermatogoniaPharmaceutical SolutionsNonprescription DrugsHistocompatibilityTransplantation ChimeraOogoniaMyelodysplastic SyndromesTime FactorsDrug UtilizationAntineoplastic Combined Chemotherapy ProtocolsAntilymphocyte SerumAntihypertensive AgentsDrug-Related Side Effects and Adverse ReactionsLeukemia, MyeloidLeukemia, Myeloid, AcutePharmacistsClinical Pharmacy Information SystemsSurvival AnalysisUnited StatesDrug EvaluationDose-Response Relationship, DrugSeminiferous TubulesPharmaceutical Preparations